ImmunoGen, Inc. (IMGN) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
830 WINTER ST WALTHAM, MA 02451 |
| State of Incorp. | MA |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 275,138 | 478,750 | 293,856 | 176,225 | 262,252 | 267,107 | |||
| Cash and cash equivalents | 275,138 | 478,750 | 293,856 | 176,225 | 262,252 | 267,107 | |||
| Receivables | 13,814 | 6,812 | 46 | 8,501 | 2,318 | 5,229 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,038 | ||||||||
| Inventory | 1,038 | ||||||||
| Other undisclosed current assets | 15,169 | 14,437 | 30,352 | 24,172 | 14,211 | 2,967 | |||
| Total current assets: | 304,121 | 499,999 | 324,254 | 208,898 | 278,781 | 276,341 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 16,196 | ||||||||
| Operating lease, right-of-use asset | 10,231 | 12,392 | 14,072 | 15,587 | ✕ | ✕ | |||
| Property, plant and equipment | 4,377 | 4,663 | 5,760 | 6,993 | 12,891 | 14,538 | |||
| Other noncurrent assets | 14,011 | 8,711 | 10,986 | 3,784 | 3,709 | 3,797 | |||
| Total noncurrent assets: | 44,815 | 25,766 | 30,818 | 26,364 | 16,600 | 18,335 | |||
| TOTAL ASSETS: | 348,936 | 525,765 | 355,072 | 235,262 | 295,381 | 294,676 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 95,247 | 46,980 | 43,478 | 32,856 | 44,463 | 36,586 | |||
| Employee-related liabilities | ✕ | ✕ | 5,469 | 4,620 | 8,991 | 11,796 | 11,473 | ||
| Accounts payable | 45,353 | 18,434 | 9,538 | 9,933 | 11,365 | 8,562 | |||
| Accrued liabilities | 49,894 | 23,077 | 29,320 | 13,932 | 21,302 | 16,551 | |||
| Deferred revenue | 13,856 | 44,351 | 29,249 | 309 | ✕ | ✕ | |||
| Debt | 2,093 | 2,971 | |||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 1,405 | ||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 317 | ✕ | ||
| Other undisclosed current liabilities | 12,755 | 9,614 | 47,503 | 41,274 | 25,880 | 17,779 | |||
| Total current liabilities: | 121,858 | 100,945 | 122,323 | 77,410 | 70,660 | 55,770 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 15,244 | 18,651 | 23,876 | 2,064 | 2,050 | ||||
| Long-term debt, excluding current maturities | 2,078 | 2,064 | 2,050 | ||||||
| Liabilities, other than long-term debt | 47,803 | 49,023 | 83,446 | 127,830 | 84,665 | 103,117 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 98,881 | ||
| Deferred revenue | 36,355 | 47,717 | 80,860 | 127,123 | ✕ | ✕ | |||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 80,485 | ✕ | ||
| Other liabilities | 300 | 1,306 | 2,586 | 707 | 4,180 | 4,236 | |||
| Operating lease, liability | 11,148 | 15,244 | 18,651 | 21,798 | ✕ | ✕ | |||
| Other undisclosed noncurrent liabilities | 23,449 | 34,967 | 41,082 | 82,267 | 127,020 | 151,634 | |||
| Total noncurrent liabilities: | 71,252 | 99,234 | 143,179 | 233,973 | 213,749 | 256,801 | |||
| Total liabilities: | 193,110 | 200,179 | 265,502 | 311,383 | 284,409 | 312,571 | |||
| Equity | |||||||||
| Equity, attributable to parent | 155,826 | 325,586 | 89,570 | (76,121) | 10,972 | (17,895) | |||
| Common stock | 2,260 | 2,204 | 1,950 | 1,501 | 1,494 | 1,325 | |||
| Additional paid in capital | 1,847,638 | 1,794,525 | 1,419,460 | 1,209,846 | 1,192,813 | 1,009,362 | |||
| Accumulated deficit | (1,694,072) | (1,471,143) | (1,331,840) | (1,287,468) | (1,183,335) | (1,028,582) | |||
| Total equity: | 155,826 | 325,586 | 89,570 | (76,121) | 10,972 | (17,895) | |||
| TOTAL LIABILITIES AND EQUITY: | 348,936 | 525,765 | 355,072 | 235,262 | 295,381 | 294,676 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 108,782 | 69,856 | 132,299 | 82,271 | 53,446 | 115,447 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (1,100) | |||||||
| Gross profit: | 108,782 | 69,856 | 132,299 | 82,271 | 53,446 | 114,347 | ||
| Operating expenses | (329,675) | (194,929) | (154,679) | (174,444) | (214,895) | (174,429) | ||
| Other undisclosed operating income | 1,100 | |||||||
| Operating loss: | (220,893) | (125,073) | (22,380) | (92,173) | (161,449) | (58,982) | ||
| Nonoperating income (expense) | 3,347 | (1,080) | 1,210 | 5,014 | 3,332 | 2,607 | ||
| Investment income, nonoperating | 4,341 | 51 | 729 | 4,424 | 4,227 | 1,146 | ||
| Other nonoperating income (expense) | (994) | (1,131) | 481 | 590 | (895) | 1,461 | ||
| Interest and debt expense | (47) | (95) | (95) | (95) | (25,955) | |||
| Loss from continuing operations before equity method investments, income taxes: | (217,546) | (126,200) | (21,265) | (87,254) | (158,212) | (82,330) | ||
| Other undisclosed loss from continuing operations before income taxes | (4,165) | (13,103) | (23,107) | (16,879) | (10,631) | (13,682) | ||
| Loss from continuing operations before income taxes: | (221,711) | (139,303) | (44,372) | (104,133) | (168,843) | (96,012) | ||
| Income tax expense (benefit) | (1,218) | |||||||
| Other undisclosed loss from continuing operations | ||||||||
| Loss from continuing operations: | (222,929) | (139,303) | (44,372) | (104,133) | (168,843) | (96,012) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (139,303) | (44,372) | (104,133) | (168,843) | (96,012) | |
| Other undisclosed net income | ||||||||
| Net loss attributable to parent: | (222,929) | (139,303) | (44,372) | (104,133) | (168,843) | (96,012) | ||
| Other undisclosed net loss available to common stockholders, basic | ||||||||
| Net loss available to common stockholders, diluted: | (222,929) | (139,303) | (44,372) | (104,133) | (168,843) | (96,012) | ||
Comprehensive Income ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (222,929) | (139,303) | (44,372) | (104,133) | (168,843) | (96,012) | ||
| Comprehensive loss, net of tax, attributable to parent: | (222,929) | (139,303) | (44,372) | (104,133) | (168,843) | (96,012) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.